tirzepatide patent expiry in india Novo Nordisk opens door to cheaper weight-loss drugs How are Indian companies making

After the intake form, you land on a checkout page for the consultation fee

As metabolism adapts, fewer calories are burned as heat, and more are reserved for essential functions

86% of adults taking Wegovy lost 5% or more weight, compared to 31% taking placebo 69% of adults taking Wegovy lost 10% or more weight, compared to 12% taking placebo 51% of adults taking Wegovy lost 15% or more weight, compared to 5% taking placebo* About 1 in 3 adults lost 46 lb or more (20% weight loss) while only 1.7% of adults on placebo experienced the same weight loss

To be considered eligible, patients must have: A Body Mass Index (BMI) of 40 or greater, and Four or more of the following diagnosed health conditions: o Type 2 diabetes o Hypertension (high blood pressure) o Cardiovascular disease (including heart disease or stroke) o Obstructive sleep apnoea o Dyslipidaemia (high cholesterol) Currently, very few patients meet these criteria

GLP-1 medications without insurance February